Prepared by MERRILL CORPORATION

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JHvxpw0h014nvlGNKULFrcDkc233DLlwhW2EqH8mo6ZsCXfMgYbDef5T3uTG+4F2 TPuvWYdmtkl0viJCE3F5Ow== 0000912057-02-003129.txt : 20020414 0000912057-02-003129.hdr.sgml : 20020414 ACCESSION NUMBER: 0000912057-02-003129 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020129 GROUP MEMBERS: CRANSHIRE CAPITAL, L.P. GROUP MEMBERS: DOWNSVIEW CAPITAL, INC. GROUP MEMBERS: EURAM CAP STRAT. "A" FUND LIMITED GROUP MEMBERS: JMJ CAPITAL, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GLYCOGENESYS INC CENTRAL INDEX KEY: 0000946661 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330231238 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-51445 FILM NUMBER: 02520484 BUSINESS ADDRESS: STREET 1: 31 ST. JAMES AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174220674 MAIL ADDRESS: STREET 1: 31 ST JAMES AVE STREET 2: 8TH FL CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: GLYCOGENESY INC DATE OF NAME CHANGE: 20011107 FORMER COMPANY: FORMER CONFORMED NAME: IGG INTERNATIONAL INC DATE OF NAME CHANGE: 19950721 FORMER COMPANY: FORMER CONFORMED NAME: SAFESCIENCE INC DATE OF NAME CHANGE: 19980401 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KOPIN MITCHELL P CENTRAL INDEX KEY: 0001116628 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 666 DUNDEE ROAD STREET 2: SUITE 1901 CITY: NORTHBROOK STATE: IL ZIP: 60062 MAIL ADDRESS: STREET 1: 666 DUNDEE ROAD STREET 2: SUITE 1901 CITY: NORTHBROOK STATE: IL ZIP: 60062 SC 13G 1 a2068969zsc13g.htm SC 13G Prepared by MERRILL CORPORATION
QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
(13d-102)

Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. )(1)

GLYCOGENESYS INC.

(Name of Issuer)
Common Stock, par value $.01 per share

(Title of Class of Securities)
		37989P101
		(CUSIP Number)
January 11, 2002

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

/ / Rule 13d-1(b)

/x/ Rule 13d-1(c)

/ / Rule 13d-1(d)

(1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

13G

CUSIP NO. 37989P101

Page 2 of 10 Pages



(1)	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
	Cranshire Capital, L.P.

(2)	CHECK THE APPROPRIATE BOX IF A	(a)	/x/
	MEMBER OF A GROUP*	(b)	/ /


(3)	SEC USE ONLY


(4)	CITIZENSHIP OR PLACE OF ORGANIZATION
	Illinois limited partnership U.S.A.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		(5)	SOLE VOTING POWER
			- -0-

		(6)	SHARED VOTING POWER
			2,777,369 shares of Common Stock

		(7)	SOLE DISPOSITIVE POWER
			- -0-

		(8)	SHARED DISPOSITIVE POWER
			2,777,369 shares of Common Stock

(9)	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,777,369 shares of Common Stock

(10)	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /


(11)	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%

(12)	TYPE OF REPORTING PERSON*
	PN

*SEE INSTRUCTIONS BEFORE FILLING OUT!

13G

CUSIP NO. 37989P101

Page 3 of 10 Pages



(1)	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
	Downsview Capital, Inc.

(2)	CHECK THE APPROPRIATE BOX IF A	(a)	/x/
	MEMBER OF A GROUP*	(b)	/ /


(3)	SEC USE ONLY


(4)	CITIZENSHIP OR PLACE OF ORGANIZATION
	Illinois corporation U.S.A.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		(5)	SOLE VOTING POWER
			- -0-

		(6)	SHARED VOTING POWER
			2,777,369 shares of Common Stock

		(7)	SOLE DISPOSITIVE POWER
			- -0-

		(8)	SHARED DISPOSITIVE POWER
			2,777,369 shares of Common Stock

(9)	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,777,369 shares of Common Stock

(10)	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /


(11)	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%

(12)	TYPE OF REPORTING PERSON*
	CO

*SEE INSTRUCTIONS BEFORE FILLING OUT!

13G

CUSIP NO. 37989P101

Page 4 of 10 Pages



(1)	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
	JMJ Capital, Inc.

(2)	CHECK THE APPROPRIATE BOX IF A	(a)	/x/
	MEMBER OF A GROUP*	(b)	/ /


(3)	SEC USE ONLY


(4)	CITIZENSHIP OR PLACE OF ORGANIZATION
	Illinois corporation U.S.A.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		(5)	SOLE VOTING POWER
			- -0-

		(6)	SHARED VOTING POWER
			2,777,369 shares of Common Stock

		(7)	SOLE DISPOSITIVE POWER
			- -0-

		(8)	SHARED DISPOSITIVE POWER
			2,777,369 shares of Common Stock

(9)	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,777,369 shares of Common Stock

(10)	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /


(11)	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%

(12)	TYPE OF REPORTING PERSON*
	CO

*SEE INSTRUCTIONS BEFORE FILLING OUT!

13G

CUSIP NO. 37989P101

Page 5 of 10 Pages



(1)	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
	EURAM Cap Strat. "A" Fund Limited

(2)	CHECK THE APPROPRIATE BOX IF A	(a)	/x/
	MEMBER OF A GROUP*	(b)	/ /


(3)	SEC USE ONLY


(4)	CITIZENSHIP OR PLACE OF ORGANIZATION
	Cayman Islands exempted company Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		(5)	SOLE VOTING POWER
			- -0-

		(6)	SHARED VOTING POWER
			2,777,369 shares of Common Stock

		(7)	SOLE DISPOSITIVE POWER
			- -0-

		(8)	SHARED DISPOSITIVE POWER
			2,777,369 shares of Common Stock

(9)	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,777,369 shares of Common Stock

(10)	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /


(11)	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%

(12)	TYPE OF REPORTING PERSON*
	CO

*SEE INSTRUCTIONS BEFORE FILLING OUT!

13G

CUSIP NO. 37989P101

Page 6 of 10 Pages



(1)	NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
	Mitchell P. Kopin

(2)	CHECK THE APPROPRIATE BOX IF A	(a)	/x/
	MEMBER OF A GROUP*	(b)	/ /


(3)	SEC USE ONLY


(4)	CITIZENSHIP OR PLACE OF ORGANIZATION
	U.S. Citizen

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		(5)	SOLE VOTING POWER
			- -0-

		(6)	SHARED VOTING POWER
			2,777,369 shares of Common Stock

		(7)	SOLE DISPOSITIVE POWER
			- -0-

		(8)	SHARED DISPOSITIVE POWER
			2,777,369 shares of Common Stock

(9)	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,777,369 shares of Common Stock

(10)	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /


(11)	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%

(12)	TYPE OF REPORTING PERSON*
	IN

*SEE INSTRUCTIONS BEFORE FILLING OUT!

Item 1(a).	Name of Issuer:
	GlycoGenesys, Inc. (the "Company")
Item 1(b).	Address of Issuer's Principal Executive Offices:
	31 St. James Avenue, Boston, Massachusetts 02116
Item 2(a).	Name of Person Filing
Item 2(b).	Address of Principal Business Office or, if None, Residence
Item 2(c).	Citizenship
	Cranshire Capital, L.P. 666 Dundee Road, Suite 1901 Northbrook, IL 60062 Illinois limited partnership
	Downsview Capital, Inc. 666 Dundee Road, Suite 1901 Northbrook, IL 60062 Illinois corporation
	JMJ Capital, Inc. 666 Dundee Road, Suite 1901 Northbrook, IL 60062 Illinois corporation
	EURAM Cap Strat. "A" Fund Limited c/o JMJ Capital, Inc. 666 Dundee Road, Suite 1901 Northbrook, IL 60062 Cayman Islands exempted company
	Mitchell P. Kopin 666 Dundee Road, Suite 1901 Northbrook, IL 60062 U.S. Citizen
Item 2(d).	Title of Class of Securities:
	Common Stock, par value $.01 per share, of the Company ("Common Stock")
Item 2(e).	CUSIP Number:
	37989P101
Item 3.	If this Statement is Filed Pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the persons filing are:
	(a)	/ /	Broker or dealer registered under Section 15 of the Exchange Act;
	(b)	/ /	Bank as defined in Section 3 (a) (6) of the Exchange Act;
	(c)	/ /	Insurance company as defined in Section 3 (a) (19) of the Exchange Act;
	(d)	/ /	Investment company registered under Section 8 of the Investment Company Act;
	(e)	/ /	An investment advisor in accordance with Rule 13d-1 (b) (1) (ii) (E);
	(f)	/ /	An employee benefit plan or endowment fund in accordance with Rule 13d-1 (b) (1) (ii) (F);

	(g)	/ /	A parent holding company or control person in accordance with Rule 13d-1 (b) (1) (ii) (G);
	(h)	/ /	A savings association as defined in Section 3 (b) of the Federal Deposit Insurance Act;
	(i)	/ /	A church plan that is excluded from the definition of an investment company under Section (c) (14) of the Investment Company Act;
	(j)	/ /	Group, in accordance with Rule 13d-1 (b) (1) (ii) (J);
	If this statement is filed pursuant to Rule 13d-1(c), check this box. /x/
Item 4.	Ownership.
	Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
	(a)	Amount beneficially owned:
		2,777,369 shares of Common Stock
	(b)	Percent of class:
		6.5%*
	(c)	Number of shares as to which such person has:
		(i)	Sole power to vote or to direct the vote — 0
		(ii)	Shared power to vote or direct the vote — 2,777,369
		(iii)	Sole power to dispose or to direct the disposition of — 0
		(iv)	Shared power to dispose or to direct the disposition of — 2,777,369
Item 5.	Ownership of Five Percent or Less of a Class.
	NOT APPLICABLE
Item 6.	Ownership of More than Five Percent on Behalf of Another Person.
	NOT APPLICABLE
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
	NOT APPLICABLE
Item 8.	Identification and Classification of Members of the Group.
	NOT APPLICABLE
Item 9.	Notice of Dissolution of Group.
	NOT APPLICABLE

Item 10.		Certification.
		By signing below, each of the undersigned certify that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose of effect.

SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

		January 29, 2002 (Date)
		CRANSHIRE CAPITAL, L.P.
		By:	Downsview Capital, Inc., its General Partner
		By:	/s/ MITCHELL P. KOPIN Mitchell P. Kopin, President
		DOWNSVIEW CAPITAL, INC.
		By:	/s/ MITCHELL P. KOPIN Mitchell P. Kopin, President
		EURAM CAP STRAT. "A" FUND LIMITED
		By:	JMJ Capital, Inc., its Investment Manager
		By:	/s/ MITCHELL P. KOPIN Mitchell P. Kopin, President
		JMJ CAPITAL, INC.
		By:	/s/ MITCHELL P. KOPIN Mitchell P. Kopin, President
		MITCHELL P. KOPIN
		/s/ MITCHELL P. KOPIN

QuickLinks

SIGNATURE
-----END PRIVACY-ENHANCED MESSAGE-----